Terray Therapeutics Grabs $120M Series B - vcnewsdaily.com

Oct 18, 2024 · Terray Therapeutics Grabs $120M Series B. Back to Home. 2024-10-18. Tweet. LOS ANGELES, CA, Terray Therapeutics has announced Series B funding of $120 million. ...

CouponFollow Extension

$120
OFF

Terray Therapeutics Grabs $120M Series B - Vcnewsdaily.com

2 weeks from now

Oct 18, 2024 · Terray Therapeutics Grabs $120M Series B. Back to Home. 2024-10-18. Tweet. LOS ANGELES, CA, Terray Therapeutics has announced Series B funding of $120 million. ...

vcnewsdaily.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

Oct 17, 2024 · Terray Therapeutics Announces Series B of $120 million to Advance its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic

businesswire.com

$120
OFF

Terray Assembles $120M Series B To Advance AI-powered Molecules

2 weeks from now

Oct 17, 2024 · Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. | Terray Therapeutics …

fiercebiotech.com

$120
OFF

Terray Therapeutics Raises $120M In Series B Funding

2 weeks from now

Oct 17, 2024 · Terray Therapeutics, a biotechnology company revolutionizing small molecule drug development, has secured $120 million in Series B funding. This latest investment brings the …

clinicaltrialvanguard.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

Oct 20, 2024 · Terray Therapeutics has raised $120 million in Series B funding, led by Bedford Ridge Capital and NVentures (NVIDIA’s venture arm), to advance its small molecule drug …

theaiinsider.tech

$120
OFF

Terray Therapeutics Closes $120M Series B Funding Round

2 weeks from now

Oct 17, 2024 · Terray Therapeutic s, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B …

finsmes.com

$120
OFF

Biotech Firm Terray Therapeutics Lands $120m Series B

2 weeks from now

Oct 17, 2024 · Terray Therapeutics, a California-based biotechnology company, has raised $120 million in Series B funding. The capital infusion will be used to progress internal programs into …

venturecapitaljournal.com

$120
OFF

Terray Therapeutics Secures $120M In Series B Funding To …

2 weeks from now

Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to advance its innovative approach to small molecule …

jacobsmgt.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

LOS ANGELES, October 17, 2024--Terray Therapeutics Announces Series B of $120 million to Advance its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic

yahoo.com

$120
OFF

Terray Assembles $120M Series B To Push AI-powered Small …

2 weeks from now

4 days ago · Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford …

biotech-insider.com

$120
OFF

Terray Therapeutics Raises $120M To Propel AI-Driven Small …

2 weeks from now

Oct 18, 2024 · Terray Therapeutics has raised $120 million in an oversubscribed Series B funding round, with hopes to advance its AI-powered small molecule drug pipeline. The funds will …

healtheconomics.com

$120
OFF

Terray Therapeutics Secures $120M Series B For Drug Innovation

2 weeks from now

Oct 17, 2024 · Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This …

investorshangout.com

$120
OFF

Terray Therapeutics Raises $120M Series B For Its AI Ways Of …

2 weeks from now

Oct 17, 2024 · Terray Therapeutics has raised a $120 million Series B round, aiming to get its first drug candidate into the clinic while advancing in its AI-fueled approach to making molecules. ...

endpts.com

$120
OFF

Terray Therapeutics Secures $120M In Series B Funding To …

2 weeks from now

Oct 17, 2024 · Terray Therapeutics, a pioneering biotechnology company dedicated to revolutionizing the small molecule therapeutics landscape, has successfully raised an …

leadsontrees.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

LOS ANGELES, October 17, 2024-- Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug …

vcaonline.com

$120
OFF

Terray Therapeutics Closes $120M Series B Funding Round

2 weeks from now

Oct 17, 2024 · Terray Therapeutic s, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B …

citybiz.co

$120
OFF

Terray Therapeutics: $120 Million (Series B) Secured To Improve …

2 weeks from now

Oct 22, 2024 · Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development …

pulse2.com

$120
OFF

Terray Therapeutics Closes Oversubscribed $120M Series B To …

2 weeks from now

Oct 17, 2024 · Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug development using …

financialcontent.com

FAQs about Terray Therapeutics Grabs $120M Series B - vcnewsdaily.com Coupon?

Who is Terray Therapeutics?

October 17, 2024, Los Angeles, CA - Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, today announced Series B funding of $120 million. ...

How much money did Terray Therapeutics raise for a series B fundraise?

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing investor NVentures—NVIDIA’s VC arm—led the funding round, which was double the size of Terray's series A, according to an Oct. 17 release. ...

How does Terray work?

Terray's platform uniquely blends experimentation and computation to deliver on the promise of generative AI for small molecule discovery—finding solutions to the toughest therapeutic challenges. To learn more about Terray visit: terraytx.com. Terray Therapeutics Media Contact [email protected] ...

Who is Terray?

Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. The company explores molecules and targets with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. ...

What is Terray doing with tnova?

The company intends to use the funds to progress internal programs into clinical trials and further enhance its integrated AI platform, tNova, which it uses to power both internal and partnered programs. Led by CEO Jacob Berlin, Terray is a biotechnology company which change the way to discover and develop small molecule therapeutics. ...

Is Terray a generative AI-driven small-molecule drug design company?

“Rapid experiments combined with advanced AI creates a molecule discovery and design flywheel able to take on the most difficult and yet to be discovered targets.” Since its Series A financing round in 2021, Terray has solidified its position as a leader in generative AI-driven small-molecule drug design. Notable milestones include: ...